摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-<1-(4-chlorobenzyl)-4-methyl-6-<(5-phenylpyridin-2-yl)ethylene>-4,5-dihydro-1H-thiopyrano<2,3,4-c,d>indol-2-yl>-3,3-dimethylbutyronitrile | 150461-56-6

中文名称
——
中文别名
——
英文名称
4-<1-(4-chlorobenzyl)-4-methyl-6-<(5-phenylpyridin-2-yl)ethylene>-4,5-dihydro-1H-thiopyrano<2,3,4-c,d>indol-2-yl>-3,3-dimethylbutyronitrile
英文别名
——
4-<1-(4-chlorobenzyl)-4-methyl-6-<(5-phenylpyridin-2-yl)ethylene>-4,5-dihydro-1H-thiopyrano<2,3,4-c,d>indol-2-yl>-3,3-dimethylbutyronitrile化学式
CAS
150461-56-6
化学式
C37H34ClN3S
mdl
——
分子量
588.216
InChiKey
XZIFZJFQNDMHFT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.09
  • 重原子数:
    42.0
  • 可旋转键数:
    8.0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    41.61
  • 氢给体数:
    0.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-<1-(4-chlorobenzyl)-4-methyl-6-<(5-phenylpyridin-2-yl)ethylene>-4,5-dihydro-1H-thiopyrano<2,3,4-c,d>indol-2-yl>-3,3-dimethylbutyronitrile 在 palladium on activated charcoal 氢气三正丁基叠氮化锡 作用下, 以 甲醇乙酸乙酯邻二氯苯 为溶剂, 反应 19.0h, 生成 5-<3-<1-(4-chlorobenzyl)-4-methyl-6-<(5-phenylpyridin-2-yl)ethyl>-4,5-dihydro-1H-thiopyrano<2,3,4-c,d>indol-2-yl>-2,2-dimethylpropyl>-1H-tetrazole
    参考文献:
    名称:
    Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816
    摘要:
    Thiopyrano[2,3,4-c,d]indoles are a new class of 5-lipoxygenase (5-LO) inhibitors. SAR studies have demonstrated that the thiopyran ring, the 5-phenylpyridine substituent, and an acidic functional group on a four-carbon C-2 side chain are all required for optimal inhibitor potency. In contrast, the indolic nitrogen may be substituted with a variety of lipophilic groups. As a result of the SAR investigation, 44 (L-691,816; 5-[3-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5-dihydro-1H-thiopyrano[2,3,4-c,d]indol-2-yl]-2,2-dimethylpropyl]-1H-tetrazole) has been identified as a potent inhibitor of the 5-LO reaction both in vitro and in a range of in vivo models. Compound 44 inhibits 5-HPETE production by both rat and human 5-LO and LTB4 synthesis in human PMN leukocytes (IC50s 16,75, and 10 nM, respectively). The mechanism of inhibition of 5-LO activity by compound 44 appears to involve the formation of a reversible deadend complex with the enzyme and does not involve reduction of the nonheme iron of 5-LO. Compound 44 is highly selective for 5-LO when compared to the inhibition of human FLAP, porcine 12-LO, and also ram seminal vesicle cyclooxygenase. In addition, 44 is orally active in a rat pleurisy model (inhibition of LTB4, ED50 = 1.9 mg/kg; 8 h pretreatment) as well as in the hyperreactive rat model of antigen-induced dyspnea (ED50 = 0.1 mg/kg;2-h pretreatment). Excellent functional activity was also observed in both the conscious allergic monkey and sheep models of asthma. In the latter case, the functional activity observed correlated with the inhibition of urinary LTE4 excretion.
    DOI:
    10.1021/jm00071a008
  • 作为产物:
    参考文献:
    名称:
    Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816
    摘要:
    Thiopyrano[2,3,4-c,d]indoles are a new class of 5-lipoxygenase (5-LO) inhibitors. SAR studies have demonstrated that the thiopyran ring, the 5-phenylpyridine substituent, and an acidic functional group on a four-carbon C-2 side chain are all required for optimal inhibitor potency. In contrast, the indolic nitrogen may be substituted with a variety of lipophilic groups. As a result of the SAR investigation, 44 (L-691,816; 5-[3-[1-(4-chlorobenzyl)-4-methyl-6-[(5-phenylpyridin-2-yl)methoxy]-4,5-dihydro-1H-thiopyrano[2,3,4-c,d]indol-2-yl]-2,2-dimethylpropyl]-1H-tetrazole) has been identified as a potent inhibitor of the 5-LO reaction both in vitro and in a range of in vivo models. Compound 44 inhibits 5-HPETE production by both rat and human 5-LO and LTB4 synthesis in human PMN leukocytes (IC50s 16,75, and 10 nM, respectively). The mechanism of inhibition of 5-LO activity by compound 44 appears to involve the formation of a reversible deadend complex with the enzyme and does not involve reduction of the nonheme iron of 5-LO. Compound 44 is highly selective for 5-LO when compared to the inhibition of human FLAP, porcine 12-LO, and also ram seminal vesicle cyclooxygenase. In addition, 44 is orally active in a rat pleurisy model (inhibition of LTB4, ED50 = 1.9 mg/kg; 8 h pretreatment) as well as in the hyperreactive rat model of antigen-induced dyspnea (ED50 = 0.1 mg/kg;2-h pretreatment). Excellent functional activity was also observed in both the conscious allergic monkey and sheep models of asthma. In the latter case, the functional activity observed correlated with the inhibition of urinary LTE4 excretion.
    DOI:
    10.1021/jm00071a008
点击查看最新优质反应信息